XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Incentive Plans and Stock-Based Compensation
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Equity Incentive Plans and Stock-Based Compensation

8. Equity Incentive Plans and Stock-Based Compensation

As of June 30, 2022, there were 2,133,880 shares available for future issuance under the 2020 Equity Incentive Plan and 500,000 shares available for future issuance under the 2022 Inducement Equity Incentive Plan, which was adopted on March 1, 2022. The 2020 Equity Incentive Plan provides for the grants of stock options and other equity-based awards to employees, non-employee directors and consultants of the Company. The 2022 Inducement Equity Incentive Plan provides for the grants of equity-based awards to individuals not previously employees or non-employee directors of the Company.

The table below summarizes the total stock-based compensation expense included in the Company’s statements of operations and comprehensive loss for the periods presented (in thousands):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

$

1,587

 

 

$

1,264

 

 

$

3,155

 

 

$

2,331

 

General and administrative

 

2,505

 

 

 

1,949

 

 

 

4,882

 

 

 

3,626

 

Total stock-based compensation expense

$

4,092

 

 

$

3,213

 

 

$

8,037

 

 

$

5,957

 

 

Stock Options

The following table summarizes the stock option activity for the six months ended June 30, 2022:

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2021

 

 

5,268,320

 

 

$

14.16

 

 

 

 

 

 

 

Granted

 

 

1,757,035

 

 

 

8.13

 

 

 

 

 

 

 

Exercised

 

 

(46,889

)

 

 

1.65

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(324,389

)

 

 

16.94

 

 

 

 

 

 

 

Outstanding at June 30, 2022

 

 

6,654,077

 

 

$

12.51

 

 

 

8.0

 

 

$

4,449

 

Exercisable at June 30, 2022

 

 

3,087,337

 

 

$

10.05

 

 

 

6.9

 

 

$

3,935

 

 

The fair value of stock option awards to employees, executives, directors, and other service providers was estimated at the date of grant using the Black-Scholes-Merton option pricing model with the following assumptions:

 

 

 

Six Months Ended
June 30,

 

 

2022

 

2021

Risk-free interest rate

 

1.47% - 3.34%

 

0.60% - 1.15%

Expected volatility

 

82.98% - 87.60%

 

85.31% - 88.43%

Expected term (in years)

 

5.50-6.08

 

5.50 - 6.08

Expected dividend yield

 

0%

 

0%

 

 

The Company recognized stock-based compensation expense related to the vesting of stock options of $3.8 million and $3.2 million during the three months ended June 30, 2022 and 2021, respectively, and $7.5 million and $6.0 million during the six months ended June 30, 2022 and 2021, respectively. The total unrecognized compensation expense related to outstanding unvested stock-option awards as of June 30, 2022, was $35.8 million, which is expected to be recognized over a weighted-average remaining service period of 2.8 years.

Restricted Stock Units

The following table summarizes the restricted stock unit activity for the six months ended June 30, 2022:

 

 

 

Number of Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Outstanding at December 31, 2021

 

 

 

 

$

 

Granted

 

 

249,018

 

 

 

8.84

 

Vested

 

 

 

 

 

 

Forfeited

 

 

(12,076

)

 

 

9.48

 

Outstanding at June 30, 2022

 

 

236,942

 

 

$

8.81

 

The Company recognized stock-based compensation expense related to the vesting of restricted stock units of $0.2 million and $0.3 million during the three and six months ended June 30, 2022, respectively. The Company did not grant restricted stock units in 2021. Total unrecognized compensation expense related to restricted stock units as of June 30, 2022, was $1.8 million, which is expected to be recognized over a weighted-average remaining service period of 2.5 years.

Employee Stock Purchase Plan

The company recognized stock-based compensation expense related to the Employee Stock Purchase Plan (ESPP) of $0.1 million and $0.2 million during the three and six months ended June 30, 2022, respectively. There was no ESPP expense for the three and six months ended June 30, 2021.

Net Loss per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Options to purchase common stock

 

6,654,077

 

 

 

5,206,688

 

 

 

6,654,077

 

 

 

5,206,688

 

 Non-vested restricted stock units

 

236,942

 

 

 

 

 

 

236,942

 

 

 

 

Total

 

6,891,019

 

 

 

5,206,688

 

 

 

6,891,019

 

 

 

5,206,688